Bial - Portela C S.a.
Clinical trials sponsored by Bial - Portela C S.a., explained in plain language.
-
Italian study tracks Parkinson's drug in everyday life
Disease control Recruiting nowThis study aims to observe how well the medication opicapone works and how safe it is for people with Parkinson's disease who are experiencing early motor fluctuations. It will follow 200 patients in Italy for up to two years as they take opicapone alongside their standard levodo…
Sponsor: Bial - Portela C S.A. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Real-World look at Parkinson's drug aims to Fine-Tune dosing for patients
Disease control Recruiting nowThis study aims to learn how Parkinson's disease patients in real life use a medication called SL-APO to manage their 'off' episodes, when symptoms return. Researchers will observe 90 patients as they and their doctors work to find the most effective and tolerable dose. The goal …
Sponsor: Bial - Portela C S.A. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC